71,994 Shares in Ralliant Corporation $RAL Purchased by Quantbot Technologies LP

Quantbot Technologies LP bought a new position in Ralliant Corporation (NYSE:RAL) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 71,994 shares of the company’s stock, valued at approximately $5,301,000.

Other institutional investors have also made changes to their positions in the company. Dunhill Financial LLC bought a new stake in Ralliant during the second quarter valued at $25,000. Global Retirement Partners LLC bought a new position in shares of Ralliant in the 2nd quarter worth about $35,000. Danske Bank A S acquired a new position in shares of Ralliant in the 4th quarter valued at about $25,000. Persistent Asset Partners Ltd acquired a new position in shares of Ralliant in the 2nd quarter valued at about $37,000. Finally, Allworth Financial LP grew its position in shares of Ralliant by 134.4% during the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock valued at $26,000 after buying an additional 293 shares during the last quarter.

Ralliant Stock Down 0.3%

Ralliant stock opened at $63.72 on Friday. The company has a 50-day simple moving average of $68.94 and a 200-day simple moving average of $55.92. The firm has a market capitalization of $7.05 billion, a P/E ratio of -5.87, a P/E/G ratio of 2.36 and a beta of 1.60. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. Ralliant Corporation has a one year low of $37.27 and a one year high of $75.41.

Ralliant (NYSE:RAL) last released its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, topping analysts’ consensus estimates of $0.63 by $0.05. The business had revenue of $567.80 million for the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, equities analysts expect that Ralliant Corporation will post 2.87 earnings per share for the current year.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a $0.05 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is presently -1.84%.

Insider Activity at Ralliant

In other news, SVP Karen M. Bick sold 6,062 shares of Ralliant stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $72.00, for a total transaction of $436,464.00. Following the sale, the senior vice president owned 31,668 shares of the company’s stock, valued at approximately $2,280,096. The trade was a 16.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of Ralliant stock in a transaction that occurred on Friday, August 14th. The shares were sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer directly owned 251,967 shares in the company, valued at approximately $18,088,710.93. This trade represents a 4.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on RAL shares. Oppenheimer increased their price objective on shares of Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Weiss Ratings restated a “sell (d)” rating on shares of Ralliant in a research note on Friday, July 31st. Royal Bank Of Canada upped their target price on Ralliant from $71.00 to $73.00 and gave the company a “sector perform” rating in a report on Friday, July 31st. Evercore began coverage on Ralliant in a research report on Tuesday, June 9th. They set an “outperform” rating and a $80.00 price target on the stock. Finally, Wall Street Zen raised Ralliant from a “buy” rating to a “strong-buy” rating in a report on Saturday. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Ralliant currently has an average rating of “Moderate Buy” and a consensus target price of $75.70.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.